{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:45:50Z","timestamp":1785545150706,"version":"3.56.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.det.2023.12.005","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T01:20:52Z","timestamp":1705800052000},"page":"267-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pediatric Neutrophilic Dermatoses"],"prefix":"10.1016","volume":"42","author":[{"given":"Ester","family":"Moreno-Artero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Torrelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2023.12.005_bib1","series-title":"Dermatology","first-page":"453","article-title":"Neutrophilic dermatosis","author":"Davis","year":"2018"},{"key":"10.1016\/j.det.2023.12.005_bib2","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/jdv.15730","volume":"33","author":"Bucchia","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2023.12.005_bib3","series-title":"Torrelo A. Schachner & Hansen pediatric Dermatology","first-page":"759","article-title":"Neutrophilic and eosinophilic diseases","author":"Levy","year":"2023"},{"key":"10.1016\/j.det.2023.12.005_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-2-34","article-title":"Sweet\u2019s syndrome - a comprehensive review of an acute febrile neutrophilic dermatosis","volume":"2","author":"Cohen","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.det.2023.12.005_bib5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1525-1470.2009.00952.x","article-title":"Pediatric sweet syndrome: case report and literature review","volume":"26","author":"Halpern","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.det.2023.12.005_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0738-081X(93)90112-P","article-title":"Sweet\u2019s syndrome and cancer","volume":"11","author":"Cohen","year":"1993","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.det.2023.12.005_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1442-9071.1992.tb00951.x","article-title":"Limbal nodules in Sweet\u2019s syndrome","volume":"20","author":"Davies","year":"1992","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.det.2023.12.005_bib8","doi-asserted-by":"crossref","first-page":"e1353","DOI":"10.1542\/peds.2011-1854","article-title":"Neonatal Sweet syndrome: a potential marker of serious systemic illness","volume":"129","author":"Gray","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.det.2023.12.005_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1067\/mjd.2003.328","article-title":"Familial Sweet\u2019s syndrome in 2 brothers, both seen in the first 2 weeks of life","volume":"49","author":"Parsapour","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.12.005_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00043426-200403000-00011","article-title":"Sweet syndrome developing during treatment with all-trans retinoic acid in a child with acute myelogenous leukaemia","volume":"26","author":"Al-Saad","year":"2004","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.det.2023.12.005_bib11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00043426-199608000-00009","article-title":"Sweet syndrome in a child with aplastic anemia receiving recombinant granulocyte colony stimulating factor","volume":"18","author":"Shimizu","year":"1996","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.det.2023.12.005_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1525-1470.2011.01534.x","article-title":"Sweet syndrome in children","volume":"29","author":"Uihlein","year":"2012","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.det.2023.12.005_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/15513818309040658","article-title":"Postinflammatory elastolysis and cutis laxa: report of a case with aortitis","volume":"1","author":"Christensen","year":"1983","journal-title":"Pediatr Pathol"},{"key":"10.1016\/j.det.2023.12.005_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-3476(83)80529-0","article-title":"Fatal cardiovascular disease and cutis laxa following acute febrile neutrophilic dermatosis","volume":"102","author":"Muster","year":"1983","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.det.2023.12.005_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002469900468","article-title":"Cardiovascular involvement in a boy with Sweet\u2019s syndrome","volume":"20","author":"Guia","year":"1999","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.det.2023.12.005_bib16","first-page":"285","article-title":"Sweet syndrome, cutis laxa, and fatal cardiac manifestations in a 2-year-old girl","volume":"38","author":"Guhamajumdar","year":"2011","journal-title":"Texas Heart Institute J"},{"key":"10.1016\/j.det.2023.12.005_bib17","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/archderm.1995.01690220081015","article-title":"Sweet\u2019s syndrome leading to acquired cutis laxa (Marshall\u2019s syndrome) in an infant with alpha 1-antitrypsin deficiency","volume":"131","author":"Hwang","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2023.12.005_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0738-081X(99)00129-7","article-title":"Sweet\u2019s syndrome: A neutrophilic dermatosis classically associated with acute onset and fever","volume":"18","author":"Cohen","year":"2000","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.det.2023.12.005_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-4362.1996.tb01607.x","article-title":"Sweet\u2019s syndrome","volume":"35","author":"Fitzgerald","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2023.12.005_bib20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4065\/70.3.234","article-title":"Sweet\u2019s syndrome: systemic signs and symptoms and associated disorders","volume":"70","author":"Fett","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.det.2023.12.005_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00007611-199402000-00009","article-title":"Sweet\u2019s syndrome in children","volume":"87","author":"Boatman","year":"1994","journal-title":"South Med J"},{"key":"10.1016\/j.det.2023.12.005_bib22","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1200\/JCO.1988.6.12.1887","article-title":"Malignancy-associated Sweet\u2019s syndrome: a review of the world literature","volume":"6","author":"Cohen","year":"1988","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.det.2023.12.005_bib23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/ijd.13584","article-title":"Pediatric pyoderma gangrenosum: a systematic review and update","volume":"56","author":"Kechichian","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2023.12.005_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-2-19","article-title":"Pyoderma gangrenosum-a review","volume":"2","author":"Wollina","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.det.2023.12.005_bib25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40257-017-0251-7","article-title":"Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment","volume":"18","author":"Alavi","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.det.2023.12.005_bib26","first-page":"e376","article-title":"Infliximab is an appropriate second-line therapy in infants with steroid refractory pyoderma gangrenosum","volume":"36","author":"Tantcheva-Poor","year":"2022","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2023.12.005_bib27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s40257-022-00699-8","article-title":"Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments","volume":"23","author":"Maronese","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.det.2023.12.005_bib28","doi-asserted-by":"crossref","first-page":"2235040","DOI":"10.1080\/09546634.2023.2235040","article-title":"Pyoderma gangrenosum and Beh\u00e7et's-like disease induced by secukinumab: a paradoxical drug reaction","volume":"34","author":"Avc\u0131","year":"2023","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.det.2023.12.005_bib29","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.3389\/fimmu.2019.02830","article-title":"Treating the Different Phenotypes of Beh\u00e7et's Syndrome","volume":"10","author":"Bettiol","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.det.2023.12.005_bib30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40272-022-00548-5","article-title":"Treatment Options in Pediatric Beh\u00e7et's Disease","volume":"25","author":"Giani","year":"2023","journal-title":"Paediatr Drugs"},{"issue":"9","key":"10.1016\/j.det.2023.12.005_bib31","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/ijd.16765","article-title":"Neutrophilic eccrine hidradenitis: a retrospective study","volume":"62","author":"Isaq","year":"2023","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2023.12.005_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12969-023-00817-8","article-title":"Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS\/CANDLE, SAVI, And AGS)","volume":"21","author":"Kanazawa","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"10.1016\/j.det.2023.12.005_bib33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41423-020-0519-3","article-title":"\"Autoinflammatory psoriasis\"-genetics and biology of pustular psoriasis","volume":"18","author":"Uppala","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"10.1016\/j.det.2023.12.005_bib34","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/annrheumdis-2021-221801","volume":"81","author":"Romano","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.det.2023.12.005_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12969-019-0338-1","article-title":"Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents","volume":"17","author":"Hospach","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"issue":"17","key":"10.1016\/j.det.2023.12.005_bib36","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s40265-022-01801-4","article-title":"Spesolimab: First Approval","volume":"82","author":"Blair","year":"2022","journal-title":"Drugs"},{"issue":"15","key":"10.1016\/j.det.2023.12.005_bib37","first-page":"4369","article-title":"Variant in the PLCG2 Gene May Cause a Phenotypic Overlap of APLAID\/PLAID: Case Series and Literature Review","volume":"11","author":"Welzel","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.det.2023.12.005_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1525-1470.1994.tb00065.x","article-title":"Pyoderma gangrenosum in infants and children","volume":"11","author":"Graham","year":"1994","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.det.2023.12.005_bib39","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/art.34332","article-title":"Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne)","volume":"64","author":"Demidowich","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.det.2023.12.005_bib40","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jamadermatol.2013.2907","article-title":"Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene","volume":"149","author":"Marzano","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2023.12.005_bib41","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/bjd.13668","article-title":"First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome","volume":"173","author":"Duchatelet","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.12.005_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/pde.12990","article-title":"Pediatric Pyoderma gangrenosum: A retrospective review of clinical features, etiologic associations, and treatment","volume":"34","author":"Schoch","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.det.2023.12.005_bib43","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/archderm.1984.01650420067018","article-title":"Pyoderma gangrenosum in childhood","volume":"120","author":"Powell","year":"1984","journal-title":"Arch Dermatology"},{"key":"10.1016\/j.det.2023.12.005_bib44","first-page":"173","article-title":"Pyoderma gangrenosum: a review of 86 patients","volume":"55","author":"Powell","year":"1985","journal-title":"Quarterly J Med"},{"key":"10.1016\/j.det.2023.12.005_bib45","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MD.0b013e318187cc9c","article-title":"Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: A cohort study of 2402 patients","volume":"87","author":"Farhi","year":"2008","journal-title":"Medicine"},{"key":"10.1016\/j.det.2023.12.005_bib46","first-page":"287","article-title":"Pyoderma gangrenosum. Mt Sinai","volume":"68","author":"Blitz","year":"2001","journal-title":"J\u00a0Med"},{"key":"10.1016\/j.det.2023.12.005_bib47","first-page":"455","article-title":"The cutaneous manifestations of gastrointestinal disease","volume":"23","author":"Katz","year":"1996","journal-title":"PrimaryCare"},{"issue":"6","key":"10.1016\/j.det.2023.12.005_bib48","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/annrheumdis-2015-208491","article-title":"Consensus classification criteria for paediatric Beh\u00e7et\u2019s disease from a prospective observational cohort: PEDBD","volume":"75","author":"Lesmeister","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.det.2023.12.005_bib49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/pde.14859","article-title":"Pediatric Beh\u04abet disease: Update in diagnosis and management","volume":"39","author":"Burns","year":"2022","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"10.1016\/j.det.2023.12.005_bib50","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1038\/eye.2008.397","article-title":"Uveitis in juvenile Beh\u00e7et's disease: clinical course and visual outcome compared with adult patients","volume":"23","author":"Kramer","year":"2009","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.det.2023.12.005_bib51","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jaad.2007.10.452","article-title":"Demographic and clinical properties of juvenile-onset Beh\u00e7et's disease: a controlled multicenter study","volume":"58","author":"Karincaoglu","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.12.005_bib52","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1007\/s10067-016-3187-z","article-title":"Paediatric Beh\u00e7et's disease: a UK tertiary centre experience","volume":"35","author":"Nanthapisal","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.det.2023.12.005_bib53","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12969-017-0213-x","article-title":"A\u00a0national cohort study on pediatric Beh\u00e7et's disease: cross-sectional data from an Italian registry","volume":"15","author":"Gallizzi","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"issue":"Suppl 1","key":"10.1016\/j.det.2023.12.005_bib54","first-page":"1","article-title":"Pediatric Beh\u00e7et's disease - clinical aspects and current concepts","volume":"7","author":"Y\u0131ld\u0131z","year":"2019","journal-title":"Eur J Rheumatol"},{"issue":"1","key":"10.1016\/j.det.2023.12.005_bib55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00296-018-4208-9","article-title":"Diagnostic\/classification criteria in pediatric Beh\u00e7et's disease","volume":"39","author":"Batu","year":"2019","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.det.2023.12.005_bib56","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jaad.2017.11.064","article-title":"Neutrophilic dermatoses: pathogenesis, Sweet syndrome, neutrophilic eccrine hidradenitis, and Behcet disease","volume":"79","author":"Nelson","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.12.005_bib57","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/archderm.1982.01650160053024","article-title":"Neutrophilic eccrine hidradenitis. A distinctive type of neutrophilic dermatosis associated with myelogenous leukemia and chemotherapy","volume":"118","author":"Harrist","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2023.12.005_bib58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s004319900193","article-title":"Idiopathic palmoplantar eccrine hidradenitis in children","volume":"160","author":"Ben-Amitai","year":"2001","journal-title":"Eur J Pediatr"},{"issue":"5","key":"10.1016\/j.det.2023.12.005_bib59","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJM200108023450504","article-title":"The pseudomonas hot-foot syndrome","volume":"345","author":"Fiorillo","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.det.2023.12.005_bib60","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaad.2009.04.046","article-title":"Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome","volume":"62","author":"Torrelo","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.det.2023.12.005_bib61","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/DAD.0000000000000340","article-title":"Histologic and Immunohistochemical Features of the Skin Lesions in CANDLE Syndrome","volume":"37","author":"Torrelo","year":"2015","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"10.1016\/j.det.2023.12.005_bib62","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/annrheumdis-2021-221814","article-title":"The 2021 European Alliance of Associations for Rheumatology\/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE\/PRAAS, SAVI and AGS","volume":"81","author":"Cetin Gedik","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.det.2023.12.005_bib63","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3389\/fimmu.2017.00927","article-title":"CANDLE Syndrome As a Paradigm of Proteasome-Related Autoinflammation","volume":"8","author":"Torrelo","year":"2017","journal-title":"Front Immunol"},{"issue":"Suppl 110","key":"10.1016\/j.det.2023.12.005_bib64","first-page":"32","article-title":"A\u00a0dermatologic perspective on autoinflammatory diseases","volume":"36","author":"Marzano","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.det.2023.12.005_bib65","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.det.2023.12.005_bib66","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.det.2023.12.005_bib67","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jamadermatol.2014.5641","article-title":"Distinct Cutaneous Manifestations and Cold-Induced Leukocyte Activation Associated With PLCG2 Mutations","volume":"151","author":"Aderibigbe","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.det.2023.12.005_bib68","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10875-015-0177-x","article-title":"PLAID: a Syndrome of Complex Patterns of Disease and Unique Phenotypes","volume":"35","author":"Milner","year":"2015","journal-title":"J\u00a0Clin Immunol"},{"issue":"12","key":"10.1016\/j.det.2023.12.005_bib69","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1111\/jdv.15918","article-title":"Expanding the clinical features of autoinflammation and phospholipase C\u03b32-associated antibody deficiency and immune dysregulation by description of a novel patient","volume":"33","author":"Mor\u00e1n-Villase\u00f1or","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2023.12.005_bib70","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1525-1470.2007.00388.x","article-title":"Perforating neutrophilic and granulomatous dermatitis of the newborn-a clue to immunodeficiency","volume":"24","author":"Torrelo","year":"2007","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.det.2023.12.005_bib71","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ajhg.2012.08.006","article-title":"A\u00a0hypermorphic missense mutation in PLCG2, encoding phospholipase C\u03b32, causes a dominantly inherited autoinflammatory disease with immunodeficiency","volume":"91","author":"Zhou","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/j.det.2023.12.005_bib72","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1136\/annrheumdis-2017-211473","article-title":"A\u00a0novel Pyrin-Associated Autoinflammation with Neutrophilic Dermatosis mutation further defines 14-3-3 binding of pyrin and distinction to Familial Mediterranean Fever","volume":"76","author":"Moghaddas","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.det.2023.12.005_bib73","doi-asserted-by":"crossref","first-page":"1 466","DOI":"10.1001\/jamadermatol.2021.3899","article-title":"Homozygous MEFV Gene Variant and Pyrin-Associated Autoinflammation With Neutrophilic Dermatosis: A Family With a Novel Autosomal Recessive Mode of Inheritance","volume":"157","author":"Vahidnezhad","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"9","key":"10.1016\/j.det.2023.12.005_bib74","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1093\/rheumatology\/keaa005","article-title":"First case of pyrin-associated autoinflammation with neutrophilic dermatosis complicated by amyloidosis","volume":"59","author":"Kiyota","year":"2020","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.det.2023.12.005_bib75","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10875-019-00638-z","article-title":"CAPS and NLRP3","volume":"39","author":"Booshehri","year":"2019","journal-title":"J\u00a0Clin Immunol"},{"issue":"4","key":"10.1016\/j.det.2023.12.005_bib76","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1177\/0961203317736145","article-title":"Neutrophilic urticarial dermatosis and Sweet-like neutrophilic dermatosis: under-recognized neutrophilic dermatoses in lupus erythematosus","volume":"27","author":"Lee","year":"2018","journal-title":"Lupus"},{"issue":"12","key":"10.1016\/j.det.2023.12.005_bib77","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1600-0560.2007.00758.x","article-title":"Non-bullous neutrophilic dermatosis within neonatal lupus erythematosus","volume":"34","author":"Satter","year":"2007","journal-title":"J\u00a0Cutan Pathol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863523001109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863523001109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:48:33Z","timestamp":1760006913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863523001109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0733863523001109"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2023.12.005","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Neutrophilic Dermatoses","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2023.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}